<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>S384</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.amendfooter, li.amendfooter, div.amendfooter
	{mso-style-name:amendfooter;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>SENATE, No. 384 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  JOSEPH PENNACCHIO</p>

<p class=bpuSponsor>District 26 (Morris and Passaic)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Modifies New Jersey Tort Claims Act to provide for
State to be strictly liable for injuries caused by State-mandated vaccines. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     Introduced Pending Technical Review by Legislative
Counsel.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> concerning liability for vaccine-related injuries,
amending various parts of the statutory law, and supplementing Title 59 of the
New Jersey Statutes</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>      1.   N.J.S.59:6-3 is amended
to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>      59:6-3.    <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>Neither<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>a. Except
as otherwise provided by subsection b. of this section, neither</u> a public
entity nor a public employee is liable for an injury resulting from the
decision to perform or not to perform any act to promote the public health of
the community by preventing disease or controlling the communication of disease
within the community.</p>

<p class=MsoNormal style='line-height:150%'>      <u>b.   Notwithstanding the
provisions of this or any other section of law to the contrary, a public entity
is strictly liable for injury caused by the administration of a vaccine that is
intended to prevent the communication of disease within the community if the
plaintiff establishes that:  </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the vaccine was
mandated by State law, rule, or regulation as a condition of attendance at a
child care center, preschool program, elementary or secondary school, or
institution of higher education at the time of the vaccines administration;</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the vaccine was administered
by a public employee or any other person authorized to ensure compliance with
the States vaccination requirements; and</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(3)   the injury was
proximately caused by the administration of the vaccine.  For the purposes of
this paragraph, documentation of a final determination of vaccine injury issued
through the Vaccine Injury Compensation Program administered by the Health
Resources and Services Administration in the United States Department of Health
and Human Services or a final judgment issued by a court of competent
jurisdiction that includes a finding of vaccine injury shall constitute prima
facie evidence that the injury was proximately caused by the administration of
the vaccine.  </u></p>

<p class=MsoNormal style='line-height:150%'>      <u>c.    Any damages awarded
to an individual pursuant to subsection b. of this section shall be reduced by
any amount for which the individual received compensation from any other
source, including, but not limited to, compensation paid under an insurance
policy, by a State or federal health benefits program, by an entity which
provides health services on a prepaid basis, or by the Vaccine Injury
Compensation Program, regardless of whether the Vaccine Injury Compensation
Program issued a final determination of vaccine injury.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.    For the purposes of
42 U.S.C. s.300aa-15, the provisions of this section shall not constitute a
State compensation program.</u></p>

<p class=MsoNormal style='line-height:150%'>(cf: N.J.S.59:6-3)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.    Section 1 of P.L.2003,
c.51 (C.59:6-8) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     1.    <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>Notwithstanding<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>a. Except
as otherwise provided by subsections b. and e. of this section, and
notwithstanding</u> any other provision of law to the contrary, a public entity
or public employee shall not be liable in any civil action for damages as a
result of the public entity's or public employee's acts of commission or
omission arising out of and in the course of the acquisition, stockpiling,
distribution<u>,</u> or dispensing by the public entity or public employee of
drugs and vaccines <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>which<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>that</u>
mitigate the effects of exposure to nuclear, chemical<u>,</u> or biological
agents caused by an act of terrorism or arising out of a state of emergency as
declared by the Governor, including but not limited to, potassium iodide pills.
</p>

<p class=MsoNormal style='line-height:150%'>     <u>b.    Notwithstanding the
provisions of this or any other section of law to the contrary, a public entity
is strictly liable for injury caused by the administration of a vaccine that is
intended to mitigate the effects of exposure to nuclear, chemical, or biological
agents caused by an act of terrorism or arising out of a state of emergency
declared by the Governor if the plaintiff establishes that:  </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the vaccine was
mandated by State law, rule, or regulation as a condition of attendance at a
child care center, preschool program, elementary or secondary school, or
institution of higher education, or by emergency declaration, at the time of
the vaccines administration;</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the vaccine was
administered by a public employee or any other person authorized to ensure
compliance with the States vaccination requirements; and</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(3)   the injury was
proximately caused by the administration of the vaccine.  For the purposes of
this paragraph, documentation of a final determination of vaccine injury issued
through the Vaccine Injury Compensation Program administered by the Health
Resources and Services Administration in the United States Department of Health
and Human Services or a final judgment issued by a court of competent
jurisdiction that includes a finding of vaccine injury shall constitute prima
facie evidence that the injury was proximately caused by the administration of
the vaccine.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     Any damages awarded
to an individual pursuant to subsection b. of this section shall be reduced by
any amount for which the individual received compensation from any other
source, including, but not limited to, compensation paid under an insurance
policy, by a State or federal health benefits program, by an entity which
provides health services on a prepaid basis, or by the Vaccine Injury
Compensation Program, regardless of whether the Vaccine Injury Compensation
Program issued a final determination of vaccine injury.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.    For the purposes of
42 U.S.C. s.300aa-15, the provisions of this section shall not constitute a
State compensation program.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>e.</u>     Nothing in this
act shall be deemed to grant immunity to any person or entity <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>causing<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>who causes</u>
damage by a willful, wanton<u>,</u> or grossly negligent act of commission or
omission.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2003, c.51, s.1)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    N.J.S.59:9-2 is amended
to read as follows:  </p>

<p class=MsoNormal style='line-height:150%'>     59:9-2.     a.  No interest
shall accrue prior to the entry of judgment against a public entity or public
employee.</p>

<p class=MsoNormal style='line-height:150%'>     b.    <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>No<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>Except as
otherwise provided by N.J.S.59:6-3 and section 1 of P.L.2003, c.51 (C.59:6-8),
no</u> judgment shall be granted against a public entity or public employee on
the basis of strict liability, implied warranty<u>,</u> or products liability.</p>

<p class=MsoNormal style='line-height:150%'>     c.     No punitive or
exemplary damages shall be awarded against a public entity.</p>

<p class=MsoNormal style='line-height:150%'>     d.    No damages shall be
awarded against a public entity or public employee for pain and suffering
resulting from any injury; provided, however, that this limitation on the
recovery of damages for pain and suffering shall not apply in cases of
permanent loss of a bodily function, permanent disfigurement<u>,</u> or dismemberment
where the medical treatment expenses are in excess of <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>$3,600.00<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>$3,600</u>. 
For purposes of this section<u>, </u>medical treatment expenses<u></u> are
defined as the reasonable value of services rendered for necessary surgical,
medical<u>,</u> and dental treatment of the claimant for such injury, sickness<u>,</u>
or disease, including prosthetic devices and ambulance, hospital<u>,</u> or
professional nursing <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>service<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>services</u>.</p>

<p class=MsoNormal style='line-height:150%'>     e.     If a claimant receives
or is entitled to receive benefits for the injuries allegedly incurred from a
policy or policies of insurance or any other source other than a joint
tortfeasor, such benefits shall be disclosed to the court<u>,</u> and the
amount thereof<u>,</u> which duplicates any benefit contained in the award<u>,</u>
shall be deducted from any award against a public entity or public employee
recovered by such claimant; provided, however, that nothing in this <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>provision<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>subsection</u>
shall be construed to limit the rights of a beneficiary under a life insurance
policy.  No insurer or other person shall be entitled to bring an action under
a subrogation provision in an insurance contract against a public entity or
public employee.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2000, c.126, s.32)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4.    (New section)  a.  Any
public entity, other than the State, that is named as a defendant in a suit
brought pursuant to subsection b. of N.J.S.59:6-3 or subsection b. of section 1
of P.L.2003, c.51 (C.69:6-8) shall be entitled to seek and obtain
indemnification and reimbursement from the State General Fund for all monetary
damages that are paid and all other reasonable costs, including attorneys fees
and court costs, that are incurred by the public entity in association with the
resolution of the case.  Reimbursement shall be provided under this paragraph
upon the Secretary of States receipt of a claim for reimbursement and approval
of the claim by the Director of the Division of Budget and Accounting in the
Department of the Treasury.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    A claim for
reimbursement under this section shall be filed with the Secretary of State
within the same timeframe and in the same manner provided for claims for damage
or injury under chapter 8 of Title 59 of the New Jersey Statutes.  </p>

<p class=MsoNormal style='line-height:150%'>     c.     The Legislature shall
annually appropriate, from the General Fund to the Secretary of State, such
sums as the State Treasurer and the Director of the Division of Budget and
Accounting in the Department of the Treasury determine are necessary for
reimbursements authorized under this section.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     5.    This act shall take
effect immediately and shall apply to all vaccine-related injuries that are
sustained after, or that are ongoing as of, the effective date of this act.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill would make the State
strictly liable for damages stemming from certain vaccine-related injuries.  </p>

<p class=MsoNormal style='line-height:150%'>     The New Jersey Tort Claims
Act (NJTCA) provides that the public entities and public employees are to be
generally immune from civil liability in tort actions.  Public entity is
defined to include the State and any county, municipality, district, public
authority, public agency, and any other political subdivision or public body in
the State.  The NJTCA specifically immunizes all public entities and public employees
from liability for any injury resulting from the decision to perform or not to
perform any act to promote the public health of the community by preventing
disease or controlling the communication of disease within the community.  The
Act further specifies that no public entity or public employee may be held
civilly liable for any injury resulting from the public entity's or public
employee's acts of commission or omission arising out of and in the course of
the entitys or employees acquisition, stockpiling, distribution, or
dispensing of drugs and vaccines that mitigate the effects of exposure to
nuclear, chemical, or biological agents caused by an act of terrorism or
arising out of a state of emergency as declared by the Governor.  </p>

<p class=MsoNormal style='line-height:150%'>     This bill would amend the
NJTCA to specify that, notwithstanding the Acts existing immunity provisions, a
public entity will be strictly liable for an injury that is caused by the
administration of a vaccine if the plaintiff establishes that:  </p>

<p class=MsoNormal style='line-height:150%'>     1)    the vaccine was mandated
by State law, rule, or regulation as a condition of attendance at a child care
center, preschool program, elementary or secondary school, or institution of
higher education, or by emergency declaration, at the time of the vaccines
administration;</p>

<p class=MsoNormal style='line-height:150%'>     2)    the vaccine was
administered by a public employee or any other person authorized to ensure
compliance with the States vaccination requirements; and</p>

<p class=MsoNormal style='line-height:150%'>     3)    the injury was
proximately caused by the administration of the vaccine.  Documentation of a
final determination of vaccine injury, which is issued through the Vaccine
Injury Compensation Program administered by the Health Resources and Services
Administration in the United States Department of Health and Human Services, or
a final judgment issued by a court of competent jurisdiction that includes a
finding of vaccine injury will constitute prima facie evidence that the injury
was proximately caused by the administration of the vaccine.</p>

<p class=MsoNormal style='line-height:150%'>     The bill provides that any
damages awarded to an individual pursuant to its provisions are to be reduced
by any amount for which the individual has received compensation from any other
source, including, but not limited to, compensation paid under an insurance
policy, by a State or federal health benefits program, by an entity which
provides health services on a prepaid basis, or by the Vaccine Injury
Compensation Program, regardless of whether the Vaccine Injury Compensation
Program issued a final determination of vaccine injury.  The bill further
specifies that its provisions may not be deemed to constitute a State
compensation program, under 42 U.S.C. s.300aa-15, for the purposes of
determining whether compensation is available under the Vaccine Injury
Compensation Program.</p>

<p class=MsoNormal style='line-height:150%'>     Because the term public
entity, as defined in the NJTCA, includes the State as well as any county,
municipality, district, public authority, public agency, or other political
subdivision or public body, the bill would clarify that, whenever a public
entity, other than the State, is named as a defendant in a suit brought
pursuant to the bill, that entity will be entitled to seek and obtain indemnification
and reimbursement from the State General Fund for any monetary damages that are
paid and other reasonable costs that are incurred thereby in association with
the resolution of the case.  Reimbursement is be provided upon the Secretary of
States receipt of a claim for reimbursement and approval of the claim by the
Director of the Division of Budget and Accounting in the Department of the
Treasury.  A claim for reimbursement is to be submitted in accordance with the
same timeframes, and in the same manner, as is specified by the NJTCA for
claims of damage or injury. The bill provides for the Legislature to annually
appropriate, from the General Fund to the Secretary of State, such sums as the
State Treasurer and the Director of the Division of Budget and Accounting in
the Department of the Treasury determine are necessary for the reimbursements
authorized under the bill.</p>

<p class=MsoNormal style='line-height:150%'>     This bill would take effect
immediately and would apply to all vaccine-related injuries that are sustained
after, or that are ongoing as of, the effective date.</p>

</div>

</body>

</html>
